- Home
- HHS vs CVKD Comparison
HHS vs CVKD Comparison
Compare HHS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HHS | CVKD |
|---|---|---|
| Founded | 1923 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 17.3M |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HHS | CVKD |
|---|---|---|
| Price | $2.31 | $4.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 3.1K | ★ 43.4K |
| Earning Date | 03-17-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.35 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $159,570,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.23 | $4.91 |
| 52 Week High | $5.39 | $19.03 |
Technical Indicators
Market Signals| Indicator | HHS | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 28.54 | 22.86 |
| Support Level | N/A | N/A |
| Resistance Level | $3.03 | $14.21 |
| Average True Range (ATR) | 0.06 | 0.66 |
| MACD | -0.03 | -0.34 |
| Stochastic Oscillator | 16.07 | 0.00 |
Price Performance
Historical ComparisonAbout HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.